These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 3940312)
1. Lassa fever. Effective therapy with ribavirin. McCormick JB; King IJ; Webb PA; Scribner CL; Craven RB; Johnson KM; Elliott LH; Belmont-Williams R N Engl J Med; 1986 Jan; 314(1):20-6. PubMed ID: 3940312 [TBL] [Abstract][Full Text] [Related]
2. Imported Lassa fever in Germany: surveillance and management of contact persons. Haas WH; Breuer T; Pfaff G; Schmitz H; Köhler P; Asper M; Emmerich P; Drosten C; Gölnitz U; Fleischer K; Günther S Clin Infect Dis; 2003 May; 36(10):1254-8. PubMed ID: 12746770 [TBL] [Abstract][Full Text] [Related]
3. [A man with fatal Lassa fever following a stay in Sierra Leone]. Veldkamp PJ; Schippers EF Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2201-4. PubMed ID: 12467165 [TBL] [Abstract][Full Text] [Related]
4. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. Jahrling PB; Peters CJ; Stephen EL J Infect Dis; 1984 Mar; 149(3):420-7. PubMed ID: 6715898 [TBL] [Abstract][Full Text] [Related]
5. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF Virol J; 2011 Aug; 8():404. PubMed ID: 21843352 [TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of the antiviral efficacy of virazole and ribamidil in experimental Lassa fever in monkeys]. Dvoretskaia VI; Evseev AA; Bogatikov GV; Pshenichnov VA Vopr Virusol; 1990; 35(2):151-2. PubMed ID: 2389569 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever. Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247 [TBL] [Abstract][Full Text] [Related]
16. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Bausch DG; Hadi CM; Khan SH; Lertora JJ Clin Infect Dis; 2010 Dec; 51(12):1435-41. PubMed ID: 21058912 [TBL] [Abstract][Full Text] [Related]
17. Clinical, epidemiologic, and therapeutic aspects of Lassa fever. McCormick JB Med Microbiol Immunol; 1986; 175(2-3):153-5. PubMed ID: 3724661 [No Abstract] [Full Text] [Related]
18. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study. Duvignaud A; Jaspard M; Etafo IC; Gabillard D; Serra B; Abejegah C; le Gal C; Abidoye AT; Doutchi M; Owhin S; Séri B; Vihundira JK; Bérerd-Camara M; Schaeffer J; Danet N; Augier A; Ogbaini-Emovon E; Salam AP; Ahmed LA; Duraffour S; Horby P; Günther S; Adedosu AN; Ayodeji OO; Anglaret X; Malvy D; Lancet Glob Health; 2021 Apr; 9(4):e469-e478. PubMed ID: 33740408 [TBL] [Abstract][Full Text] [Related]
19. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Khan SH; Goba A; Chu M; Roth C; Healing T; Marx A; Fair J; Guttieri MC; Ferro P; Imes T; Monagin C; Garry RF; Bausch DG; Antiviral Res; 2008 Apr; 78(1):103-15. PubMed ID: 18241935 [TBL] [Abstract][Full Text] [Related]
20. Lassa fever (arenaviruses) as a public health problem. Fabiyi A Bull Pan Am Health Organ; 1976; 10(4):335-7. PubMed ID: 1026322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]